Thrombolex, Inc.
PrivateLast Round
Series A
Mar 12, 2026
Total Funding Raised
$13.82M
Company Overview
Thrombolex, Inc. is a medical device company that designs, develops, and distributes innovative endovascular catheters used in interventional procedures for patients who suffer from arterial and venous thromboembolic conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thrombolex, Inc. Comps
Public and private peers based on sector, stage, and business model.
Thrombolex, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 12, 2026 | ||||
| Series B | Jun 4, 2024 | ||||
| VC Round | Aug 30, 2022 | ||||
| VC Round | Nov 29, 2021 | ||||
| Grant | Jul 7, 2020 | ||||
Series A | Feb 3, 2020 |
Thrombolex, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series A |
| Delaware Crossing Investor Group | VC Round, Series A |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased 154% MoM, reaching 3K.
- Mar 16, 2026
Clay DeMarcus of OrbiMed joins the Board of Directors.
Thrombolex, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Thrombolex, Inc.'s valuation, stock price, and market status.